IHT Wealth Management’s HOOKIPA Pharma HOOK Stock Holding History

IHT Wealth Management’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,045	Closed	-$9.2K	–	986
2023 Q2	$9.2K	Hold	1,045	–	–	﹤0.01%	963
2023 Q1	$7.69K	Hold	1,045	–	–	﹤0.01%	945
2022 Q4	$8.46K	Sell	1,045 -16	-2%	-$173	﹤0.01%	899
2022 Q3	$14K	Hold	1,061	–	–	﹤0.01%	859
2022 Q2	$17K	Hold	1,061	–	–	﹤0.01%	725
2022 Q1	$24K	Sell	1,061 -13	-1%	-$233	﹤0.01%	757
2021 Q4	$25K	Sell	1,074 -76	-7%	-$3.06K	﹤0.01%	797
2021 Q3	$68K	Buy	1,150 +2	+0.2%	+$145	0.01%	786
2021 Q2	$105K	Buy	+1,148	New	+$153K	0.01%	906

Other funds holding HOOK

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

IHT Wealth Management's HOOK Position: Q3 2023 in Review

IHT Wealth Management sold out of HOOKIPA Pharma (HOOK) in Q3 2023, closing a stake of 1,045 shares — an estimated $9.2K sold.

IHT Wealth Management first reported a position in HOOK in Q2 2021 and held it in 9 quarters. The position peaked at $105K in Q2 2021. 44 funds tracked by Wall St. Rank hold HOOK as of Q3 2023.

IHT Wealth Management reported no remaining HOOKIPA Pharma position as of Q3 2023 after selling out during the quarter.
IHT Wealth Management sold 1,045 HOOKIPA Pharma shares in Q3 2023, an estimated $9.2K.
IHT Wealth Management first reported a position in HOOKIPA Pharma in Q2 2021 and held it in 9 quarters.
IHT Wealth Management's HOOKIPA Pharma position peaked at $105K in Q2 2021.
44 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2023.

Based on IHT Wealth Management's 13F filing for Q3 2023, filed 14 Nov 2023.